NMR spectroscopy in pharmacy.

Since drugs in clinical use are mostly synthetic or natural products, NMR spectroscopy has been mainly used for the elucidation and confirmation of structures. For the last decade, NMR methods have been introduced to quantitative analysis in order to determine the impurity profile of a drug, to characteristic the composition of drug products, and to investigate metabolites of drugs in body fluids. For pharmaceutical technologists, solid state measurements can provide information about polymorphism of drug powders, conformation of drugs in tablets etc. Micro-imaging can be used to study the dissolution of tablets, and whole-body imaging is a powerful tool in clinical diagnostics. Taken together, this review covers applications of NMR spectroscopy in drugs analysis, in particular, methods of international pharmacopoeiae, pharmaceutics and pharmacokinetics. The authors have repeated many of the methods describe in their own laboratories.

[1]  Robin K. Harris,et al.  Cross-polarization/magic-angle spinning NMR studies of polymorphism: Cortisone acetate , 1990 .

[2]  G. Balogh,et al.  Estimation of impurity profiles of drugs and related materials. Part VIII: Combined application of high-performance liquid chromatography and NMR spectroscopy in the impurity profiling of drugs. , 1991, Journal of pharmaceutical and biomedical analysis.

[3]  Mark E. Smith,et al.  Solid state NMR , 1997 .

[4]  D. Grant,et al.  Conformational analysis of DL‐, L‐ and D‐methionine by solid‐state 13C NMR spectroscopy , 1986 .

[5]  I. Wilson,et al.  19F and 1H magnetic resonance strategies for metabolic studies on fluorinated xenobiotics: application to flurbiprofen [2-(2-fluoro-4-biphenylyl)propionic acid]. , 1990, Journal of pharmaceutical and biomedical analysis.

[6]  U. Holzgrabe,et al.  Effect of β-cyclodextrin acetylation on the resolution of phenethylamines with capillary electrophoresis and nuclear magnetic resonance spectroscopy , 1997 .

[7]  Yan Xu,et al.  Fluorine-19 Nuclear Magnetic Resonance Imaging and Spectroscopy of Sevoflurane Uptake, Distribution, and Elimination in Rat Brain , 1995, Anesthesiology.

[8]  Robin K. Harris,et al.  Quantitative aspects of high-resolution solid-state nuclear magnetic resonance spectroscopy , 1985 .

[9]  C. Dobson,et al.  Combination of cross polarization/magic angle spinning NMR and x-ray crystallography: structure and dynamics in a low-symmetry molecular crystal, potassium penicillin V , 1993 .

[10]  J. Everett,et al.  A study of flucloxacillin metabolites in rat urine by two-dimensional 1H, 19F COSY NMR. , 1989, Journal of pharmaceutical and biomedical analysis.

[11]  Yoshiyuki Suzuki,et al.  Enantiorecognition of a new chiral selector, β-cyclodextrin perphenylcarbamate, as studied by NMR spectroscopy and molecular energy calculation , 1995 .

[12]  G. H. Dewar,et al.  Captopril and its probable contaminants: NMR and MS features of analytical value. , 1994, Journal of pharmaceutical and biomedical analysis.

[13]  Alejandro C. Olivieri,et al.  A simple approach for relating molecular and structural information to the dipolar coupling 13C14N in CPMAS NMR , 1987 .

[14]  I. Wilson,et al.  Identification of the Positional Isomers of 2-Fluorobenzoic acid 1-O-Acyl Glucuronide by Directly Coupled HPLC-NMR , 1995 .

[15]  G. Silvey.  Two-dimensional and deuterium-induced, differential-isotope-shift nuclear magnetic resonance characterization of potassium sucrose octasulfate and sucralfate. , 1992, Journal of pharmaceutical sciences.

[16]  L. Frydman,et al.  Solid State NMR of Drugs: Soluble Aspirin , 1987 .

[17]  C. Dobson,et al.  13C-CP/MAS NMR studies of the cyclomalto-oligosaccharide (cyclodextrin) hydrates. , 1992, Carbohydrate research.

[18]  J. Nicholson,et al.  High Resolution 1H NMR Spectroscopic Studies of the Metabolism and Excretion of Ampicillin in Rats and Amoxycillin in Rats and Man , 1994, The Journal of pharmacy and pharmacology.

[19]  J. Jaroszewski,et al.  Determination of enantiomeric purity of nicotine in pharmaceutical preparations by 13C-NMR in the presence of a chiral lanthanide shift reagent. , 1994, Journal of pharmaceutical and biomedical analysis.

[20]  G. Neville,et al.  A novel method for differentiating dextran sulfate from related sulfated polysaccharides. , 1991, Journal of pharmaceutical sciences.

[21]  Jimmy D Bell,et al.  Effect of L-alanine infusion on 31P nuclear magnetic resonance spectra of normal human liver: towards biochemical pathology in vivo. , 1992, Clinical science.

[22]  C. Lau-cam,et al.  Determination of chlorpheniramine maleate in tablets and injections by 1H-NMR spectroscopy. , 1993, Journal of pharmaceutical and biomedical analysis.

[23]  Richard J. Smith,et al.  Use of liquid chromatography-nuclear magnetic resonance spectroscopy for the identification of impurities in drug substances , 1994 .

[24]  L. Kenne,et al.  Quantitative analysis of phospholipids by 31P-NMR. , 1986, Journal of lipid research.

[25]  R. Furneaux,et al.  Observation by solid-state 3C CP MAS NMR spectroscopy of the transformations of wheat starch associated with the making and staling of bread , 1992 .

[26]  K. Holme,et al.  Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy. , 1989, Journal of pharmaceutical sciences.

[27]  I. Wilson,et al.  Investigation of the human metabolism of antipyrine using coupled liquid chromatography and nuclear magnetic resonance spectroscopy of urine. , 1993, Journal of chromatography.

[28]  P. York,et al.  Fresemide crystal forms; solid state and physicochemical analyses , 1988 .

[29]  S. Nishiura,et al.  Quality check of heparin injections by 1H-nuclear magnetic resonance spectroscopy. , 1990, Chemical & pharmaceutical bulletin.

[30]  J. Buddrus,et al.  NMR-spektroskopische Bestimmung des Enantiomerenverhältnisses ungeschützter Aminosäuren mit C2-chiralen Palladiumverbindungen , 1996 .

[31]  R. Harris,et al.  Cross-polarization/magic-angle spinning NMR studies of polymorphism: Androstanolone , 1989 .

[32]  M. Mor,et al.  Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with β‐cyclodextrin , 1997 .

[33]  J. Everett,et al.  19F NMR spectroscopy study of the metabolites of flucloxacillin in rat urine , 1985, The Journal of pharmacy and pharmacology.

[34]  B. Behnke,et al.  Capillary HPLC-NMR Coupling:  High-Resolution (1)H NMR Spectroscopy in the Nanoliter Scale. , 1996, Analytical chemistry.

[35]  A. Cheung,et al.  31P-NMR assay of phosphatidylcholine and phosphatidylethanolamine in AL721. , 1990, Journal of pharmaceutical and biomedical analysis.

[36]  D. Grant,et al.  Solid‐state 13C NMR study of drugs: Aspirin , 1986 .

[37]  T. Jefferies,et al.  HPLC and 1H-NMR study of chiral recognition in some thromboxane antagonists induced by beta-cyclodextrin. , 1991, Journal of pharmaceutical and biomedical analysis.

[38]  J. Nicholson,et al.  750 MHz 1H-NMR spectroscopy of human blood plasma. , 1993, Journal of pharmaceutical and biomedical analysis.

[39]  U. Holzgrabe,et al.  Utilizing NMR spectroscopy for assessing drug enantiomeric composition , 1998 .

[40]  Robin K. Harris,et al.  A comparative spectroscopic investigation of three pseudopolymorphs of testosterone using solid-state i.r. and high-resolution solid-state NMR , 1987 .

[41]  I. Wilson,et al.  Studies on the metabolism of fluorinated xenobiotics in the rat using 19F-NMR and 1H-NMR spectroscopy. , 1990, Journal of pharmaceutical and biomedical analysis.

[42]  M. Eichelbaum,et al.  Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  D. Dull,et al.  .alpha.-Methoxy-.alpha.-trifluoromethylphenylacetic acid, a versatile reagent for the determination of enantiomeric composition of alcohols and amines , 1969 .

[44]  J. Tyler,et al.  Use of 1H NMR in the identification of a metabolite of a catecholic cephalosporin excreted in rat bile. , 1990, Journal of pharmaceutical and biomedical analysis.

[45]  J. Sanders,et al.  NMR study of whole rat bile: the biliary excretion of cefoperazone and benzyl chloride by an isolated perfused rat liver. , 1995, Journal of pharmaceutical and biomedical analysis.

[46]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[47]  D. Parker.  NMR Determination of Enantiomeric Purity , 1991 .

[48]  C. Marchant,et al.  1D AND 2D PROTON NMR STUDIES OF THE CHIRAL RECOGNITION OF FLURBIPROFEN BY β‐CYCLODEXTRIN , 1990 .

[49]  U. Holzgrabe,et al.  1H, 19F and 13C NMR spectral data of fifteen gyrase inhibitors and some metabolites , 1994 .

[50]  G. Whitesides,et al.  Determination of enantiomeric purity of polar substrates with chiral lanthanide NMR shift reagents in polar solvents , 1987 .

[51]  B. Ross,et al.  In vivo activity of glutaminase in the brain of hyperammonaemic rats measured by 15N nuclear magnetic resonance. , 1995, The Biochemical journal.

[52]  C. Beddell,et al.  Prediction of urinary sulphate and glucuronide conjugate excretion for substituted phenols in the rat using quantitative structure-metabolism relationships. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[53]  I. Wilson,et al.  High-performance liquid chromatography coupled to high-field proton nuclear magnetic resonance spectroscopy: application to the urinary metabolites of ibuprofen. , 1993, Analytical chemistry.

[54]  P. E. Simonsen,et al.  Determination of diethylcarbamazine, an antifilarial drug, in human urine by 1H-NMR spectroscopy. , 1996, Journal of pharmaceutical and biomedical analysis.

[55]  D. Craik,et al.  Pharmaceutical Applications of NMR , 2000 .

[56]  J. Donoso,et al.  Alkaline hydrolysis of cefotaxime. A HPLC and 1H NMR study. , 1994, Journal of pharmaceutical sciences.

[57]  R. Herrmann,et al.  Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment. , 1988, Cancer research.

[58]  J. Everett,et al.  Spin-echo 1H n.m.r. spectroscopy: a new method for studying penicillin metabolism , 1984 .

[59]  J. Armand,et al.  Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry. , 1986, Cancer research.

[60]  J C Lindon,et al.  High-resolution diffusion and relaxation edited one- and two-dimensional 1H NMR spectroscopy of biological fluids. , 1996, Analytical chemistry.

[61]  M. Aida,et al.  13C NMR spectra of para‐substituted methoxybenzenes and phenols in the solid state: Examination of chemical shift non‐equivalence in ortho and meta carbons related to non‐equivalent electron distribution, and application to assignment of peaks in meso‐hexestrol and its derivatives , 1988 .

[62]  E. Morgan,et al.  Photo-isomerization of azadirachtin studied by high performance liquid chromatography coupled to high field proton NMR spectroscopy , 1994 .

[63]  J. Lindon,et al.  600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. , 1993, Journal of pharmaceutical and biomedical analysis.

[64]  U. Holzgrabe,et al.  Chiral discrimination by NMR spectroscopy of ephedrine and N-methylephedrine induced by β-cyclodextrin, heptakis(2,3-di-O-acetyl)β-cyclodextrin, and heptakis (6-O-acetyl)β-cyclodextrin , 1997 .

[65]  S. Byrn,et al.  Analysis of solid-state Carbon-13 NMR spectra of polymorphs (benoxaprofen and nabilone) and pseudopolymorphs (cefazolin). , 1985, Journal of pharmaceutical sciences.

[66]  S. Lincoln,et al.  Chiral discrimination by modified cyclodextrins , 1997 .

[67]  J. Griffiths,et al.  19F nuclear magnetic resonance imaging of drug distribution in vivo: The disposition of an antifolate anticancer drug in mice , 1991, Magnetic resonance in medicine.

[68]  G. Neville,et al.  Multinuclear NMR (1H, 13C and 19F) spectroscopic re-examination of the solvolytic behaviour of flurazepam dihydrochloride. , 1995, Journal of pharmaceutical and biomedical analysis.

[69]  Donald S. Williams,et al.  Multi‐Slice MRI of Rat Brain Perfusion During Amphetamine Stimulation Using Arterial Spin Labeling , 1995, Magnetic resonance in medicine.

[70]  M. Hofmann,et al.  Online Coupling of Supercritical Fluid Chromatography and Proton High-Field Nuclear Magnetic Resonance Spectroscopy , 1994 .

[71]  B. Müller,et al.  Interaction of prostaglandin E1 with alpha-cyclodextrin in aqueous systems: stability of the inclusion complex. , 1991, Journal of pharmaceutical sciences.

[72]  T. Racey,et al.  Physicochemical characterization of the First World Health Organization International Standard for low molecular weight heparin derivatives. , 1990, Journal of pharmaceutical sciences.

[73]  I. Wilson,et al.  A rapid method for the isolation and identification of drug metabolites from human urine using solid phase extraction and proton NMR spectroscopy. , 1986, Journal of pharmaceutical and biomedical analysis.

[74]  I. Warner,et al.  Complexation of ephedrine withβ-cyclodextrin: An NMR spectroscopy study , 1993 .

[75]  G. Sadana,et al.  Quantitative proton magnetic resonance spectroscopic determination of nifedipine and its photodecomposition products from pharmaceutical preparations. , 1991, Journal of pharmaceutical sciences.

[76]  G. Neville,et al.  Characterization and differentiation of some complex dextran sulfate preparations of medicinal interest. , 1991, Journal of pharmaceutical sciences.

[77]  U. R. Desai,et al.  Molecular weight of heparin using 13C nuclear magnetic resonance spectroscopy. , 1995, Journal of pharmaceutical sciences.

[78]  J P Shockcor,et al.  Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. , 1996, Analytical chemistry.

[79]  I. Wilson,et al.  Evaluation of liquid chromatography coupled with high‐field 1H NMR spectroscopy for drug metabolite detection and characterization: The identification of paracetamol metabolites in urine and bile , 1994, NMR in biomedicine.

[80]  H. F. Shurvell,et al.  Vibrational and NMR spectroscopic study of aged flurazepam mono- and dihydrochloride salts for content identity. , 1994, Journal of pharmaceutical sciences.

[81]  C. Branch,et al.  19F NMR imaging of cerebral blood flow , 1991, Magnetic resonance in medicine.

[82]  Stephen R. Byrn,et al.  Crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate , 1988 .

[83]  M. Spraul,et al.  Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. , 1994, Journal of pharmaceutical and biomedical analysis.

[84]  T. Schmedake,et al.  The quantitative analysis of an analgesic tablet: an nmr experiment for the instrumental analysis course , 1996 .

[85]  A. Fry.  Isotope effect studies of elimination reactions , 1972 .

[86]  R. Bassfield,et al.  Synthesis of optically active nicotinoids , 1982 .

[87]  J. Nicholson,et al.  Identification of novel hydrazine metabolites by 15N-NMR. , 1991, Biochemical pharmacology.

[88]  A. Drake,et al.  Stereochemical studies of chiral H-1 antagonists of histamine: the resolution, chiral analysis, and biological evaluation of four antipodal pairs. , 1992, Chirality.

[89]  A. Haase,et al.  Fast 19F-NMR imaging in vivo using FLASH-MRI. , 1994, Magnetic resonance imaging.

[90]  K R Morris,et al.  Solid-state NMR and IR for the analysis of pharmaceutical solids: polymorphs of fosinopril sodium. , 1993, Journal of pharmaceutical and biomedical analysis.

[91]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[92]  L. Griffiths.  Optimization of NMR and HPLC Conditions for LC-NMR , 1995 .

[93]  I. Wilson,et al.  Direct characterization of drug glucuronide isomers in human urine by HPLC-NMR spectroscopy: application to the positional isomers of 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid glucuronide. , 1996, Analytical chemistry.

[94]  I. Wilson,et al.  Derivatized β-cyclodextrins combined with high field NMR for enantiomer analysis: application to ICI 185,282 5(Z)-7-([2RS,4RS,5SR]-4- , 1991 .

[95]  Cecil Dybowski,et al.  Quantification of 13C in solids using CPMAS-DD-NMR spectroscopy , 1993 .

[96]  T. Nishikawa,et al.  Inhibition of noradrenaline release from cerebrocortical synaptosomes and stimulation of synaptosomal Na+, K+‐ATPase activity by morphine in rats , 1990, The Journal of pharmacy and pharmacology.

[97]  I. Wilson,et al.  750 MHz HPLC-NMR spectroscopic studies on the separation and characterization of the positional isomers of the glucuronides of 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid. , 1996, Analytical chemistry.

[98]  D T Lowenthal,et al.  1H‐MRS, MRI‐Based Hippocampal Volumetry, and 99mTc‐HMPAO‐SPECT in Normal Aging, Age‐Associated Memory Impairment, and Probable Alzheimer's Disease , 1996, Journal of the American Geriatrics Society.

[99]  I. Wilson,et al.  Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine. , 1987, Analytical chemistry.

[100]  G. Maciel,et al.  13C NMR Spin-Lattice Relaxation Properties and Quantitative Analytical Methodology of 13C NMR Spectroscopy for Coals , 1995 .

[101]  K. Holme,et al.  Chemical composition, particle size range, and biological activity of some low molecular weight heparin derivatives. , 1990, Journal of pharmaceutical sciences.

[102]  S. Branch,et al.  Applications of modern-high-field NMR spectroscopy in medicinal chemistry. , 1989, Progress in medicinal chemistry.

[103]  J. Lindon,et al.  Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. , 1993, Journal of pharmaceutical and biomedical analysis.

[104]  A. Casy.  Chiral discrimination by NMR spectroscopy , 1993 .

[105]  A. Mutlib,et al.  Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[106]  J. Mckillop,et al.  Quantitative 1H-NMR analysis of amniotic fluid. , 1993, Journal of pharmaceutical and biomedical analysis.

[107]  R. Martino,et al.  Application of fluorine-19 nuclear magnetic resonance to the determination of plasma-protein binding of 5'-deoxy-5-fluorouridine, a new antineoplastic fluoropyrimidine. , 1988, Journal of pharmaceutical and biomedical analysis.

[108]  U. Keller,et al.  13C NMR for the assessment of human brain glucose metabolism in vivo. , 1991, Biochemistry.

[109]  B. Dale,et al.  Carbon-13 NMR and order in cellulose , 1982 .

[110]  I. Ando,et al.  Intermolecular hydrogen-bonding effect on carbon-13 NMR chemical shifts of glycine residue carbonyl carbons of peptides in the solid state , 1988 .

[111]  U. Holzgrabe,et al.  Chiral discrimination of phenethylamines with β-cyclodextrin and heptakis(2,3-di-O-acetyl)β-cyclodextrin by capillary electrophoresis and NMR spectroscopy , 1994 .

[112]  V. Lehmann,et al.  1H-NMR microscopy of tablets. , 1995, Journal of pharmaceutical sciences.

[113]  D. Black,et al.  Utilizing nuclear magnetic resonance (NMR) spectroscopy for assessing nadolol racemate composition. , 1995, Journal of pharmaceutical and biomedical analysis.

[114]  I. Wilson,et al.  Coupling of HPLC with 19F- and 1H-NMR spectroscopy to investigate the human urinary excretion of flurbiprofen metabolites. , 1993, Journal of pharmaceutical and biomedical analysis.

[115]  A. Bernreuther,et al.  Hyphenation of high-performance liquid chromatography (HPLC) and other chromatographic techniques (SFC, GPC, GC, CE) with nuclear magnetic resonance (NMR): A review , 1996 .

[116]  J. Hirschinger,et al.  A 13C solid-state NMR study of the structure and auto-oxidation process of natural and synthetic melanins. , 1994, Biochimica et biophysica acta.

[117]  N. Szeverenyi,et al.  A quantitative one-dimensional magnetic resonance imaging technique in adjuvant arthritis: the assessment of disease progression and indomethacin efficacy. , 1995, The Journal of rheumatology.

[118]  I. Wilson,et al.  Proton magnetic resonance spectroscopy of human urine: Excretion of 1-(3'-carboxypropyl)-3,7-dimethylxanthine by man after dosing with oxpentifylline. , 1987, Journal of pharmaceutical and biomedical analysis.

[119]  J. Sanders,et al.  NMR study of whole rat bile: the biliary excretion of 4-cyano-N,N-dimethyl aniline by an isolated perfused rat liver and a liver in situ. , 1995, Journal of pharmaceutical and biomedical analysis.

[120]  Michael J. Gidley,et al.  13C CP/MAS NMR studies of amylose inclusion complexes, cyclodextrins, and the amorphous phase of starch granules: Relationships between glycosidic linkage conformation and solid-state 13C chemical shifts , 1988 .

[121]  M. Spraul,et al.  Application of the one-dimensional TOCSY pulse sequence in 750 MHz 1H-NMR spectroscopy for assignment of endogenous metabolite resonances in biofluids. , 1994, Journal of pharmaceutical and biomedical analysis.

[122]  R. W. Sears,et al.  HPLC and NMR methods for the quantitation of the (R)‐enantiomer in (−)‐(S)‐timolol maleate drug raw materials , 1994 .

[123]  P. Elving,et al.  Analytical Utilization of the Polarographic and Voltammetric Behavior of Purines and Pyrimidines. , 1962 .

[124]  A. Haase,et al.  Half-life of perfluorooctylbromide in inner organs determined by fast 19F-NMR imaging. , 1994, Advances in experimental medicine and biology.

[125]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[126]  David M. Grant,et al.  Cross polarization and magic angle sample spinning NMR spectra of model organic compounds. 1. Highly protonated molecules , 1983 .

[127]  Gerhard Krack,et al.  Strukturbestimmung von Vitamin‐A‐acetat‐Isomeren mit HPLC‐1H‐NMR‐Kopplung , 1995 .